Proficio Capital Partners LLC Makes New Investment in AdaptHealth Corp. (NASDAQ:AHCO)

Proficio Capital Partners LLC bought a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) in the fourth quarter, HoldingsChannel.com reports. The firm bought 19,040 shares of the company’s stock, valued at approximately $181,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Mutual of America Capital Management LLC increased its position in AdaptHealth by 23.8% during the third quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company’s stock valued at $178,000 after acquiring an additional 3,052 shares during the last quarter. Thrivent Financial for Lutherans increased its position in shares of AdaptHealth by 28.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 82,987 shares of the company’s stock valued at $932,000 after purchasing an additional 18,136 shares during the last quarter. Intech Investment Management LLC increased its position in shares of AdaptHealth by 223.2% during the 3rd quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock valued at $670,000 after purchasing an additional 41,196 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of AdaptHealth by 7.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,230,364 shares of the company’s stock worth $13,817,000 after purchasing an additional 81,624 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of AdaptHealth by 33.7% in the third quarter. The Manufacturers Life Insurance Company now owns 52,735 shares of the company’s stock worth $592,000 after buying an additional 13,295 shares during the last quarter. 82.67% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

AHCO has been the subject of a number of research reports. Royal Bank of Canada upped their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the company an “outperform” rating in a report on Wednesday, February 26th. UBS Group reduced their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Truist Financial lifted their target price on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Robert W. Baird upped their price target on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Finally, Canaccord Genuity Group lifted their price objective on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $13.80.

AdaptHealth Trading Up 1.5 %

Shares of AdaptHealth stock opened at $10.64 on Friday. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The company has a market capitalization of $1.43 billion, a P/E ratio of -6.45, a P/E/G ratio of 1.08 and a beta of 1.30. The company has a fifty day moving average of $10.02 and a 200 day moving average of $10.17.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.